Type 1 Interferons: Induction and Mechanisms of Antiviral Action

Type 1 Interferons: Induction and Mechanisms of Antiviral Action

Saved in:

Bibliographic Details
Main Authors:	A. N. Vasilyev, V. V. Malinovskaya, V. V. Parfenov, E. V. Dmitrieva
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/253
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Induction of Type 1, 2 and 3 Interferons by Acridone Acetates
by: S. S. Grigoryan, et al.
Published: (2020-05-01)

The effect of recombinant interferon alpha-2b on the relative content of CD56<sup>bright</sup> NK cells in the peripheral blood of pregnant women with chronic urogenital infections
by: E. N. Vyzhlova, et al.
Published: (2018-02-01)

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)

Antioxidant Impact on Specific Antiviral Activity of Human Recombinant Interferon α-2b with Respect to Herpes simplex in Cell Culture
by: A. N. Vasilyev
Published: (2020-05-01)

Viferon Suppositoria in Therapy of Relapsing Herpesvirus Infection in Women
by: A. N. Vasilyev, et al.
Published: (2020-05-01)

Disruption of Type I Interferon Induction by HIV Infection of T Cells.
by: David Jesse Sanchez, et al.
Published: (2015-01-01)

Antiviral and antibacterial peptides: Mechanisms of action
by: Mahdyeh Neghabi Hajigha, et al.
Published: (2024-11-01)

Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections
by: Patricio L. Acosta, et al.
Published: (2020-01-01)

Interferon-stimulated circHOMER1 attenuates antiviral innate immunity
by: Ao Zhang, et al.
Published: (2025-08-01)

Evaluation of the effectiveness of antiviral therapy for coronavirus infection (COVID-19) with the inclusion of recombinant interferon alpha-2b
by: A. V. Mordyk, et al.
Published: (2022-10-01)

Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus/Ganjam virus.
by: Barbara Holzer, et al.
Published: (2011-01-01)

Interferon Lambda: The Next Frontier in Antiviral Therapy?
by: Sofia Chronopoulou, et al.
Published: (2025-05-01)

Antiviral Effects of Avian Interferon-Stimulated Genes
by: Xingchen He, et al.
Published: (2024-10-01)

Induction of the pro-myelocytic leukaemia gene by type I and type II interferons
by: M. Heuser, et al.
Published: (1998-01-01)

Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
by: N. P. Kartashova, et al.
Published: (2022-12-01)

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)
by: A. V. Chzhao, et al.
Published: (2018-08-01)

Antiviral Action of Sulfated Polysaccharides
by: I. D. Makarenkova, et al.
Published: (2020-05-01)

Homeostatic antiviral protection of the neonatal gut epithelium by interferon lambda
by: Bryan Ramirez Reyes, et al.
Published: (2025-02-01)

Influence of interferon types on COVID-19 prevention and treatment
by: S. S. Saidov, et al.
Published: (2021-10-01)

New possibilities of allergen-specific immunotherapy in relation to the induction of antiviral immunity in patients with bronchial asthma
by: A. V. Maksimova
Published: (2024-06-01)

Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity
by: Victoria Gonzalez, et al.
Published: (2025-07-01)

Antiviral Activity of Recombinant Interferon-a-2b in Combination with Certain Antioxidant
by: A. N. Vasilev, et al.
Published: (2020-05-01)

Antiviral Activity of Carbon Dots: Strategies and Mechanisms of Action
by: Plinio Innocenzi, et al.
Published: (2025-03-01)

Chemical mechanisms of non-thermal plasma action on cells
by: R. Ya. Olovyannikova, et al.
Published: (2020-12-01)

Interference without interferon: interferon-independent induction of interferon-stimulated genes and its role in cellular innate immunity
by: Shachee Swaraj, et al.
Published: (2024-10-01)

Antiviral Activity of Double-Stranded Ribonucleic Acid and Interferon Alpha Composition in the Model of Experimental Influenza Infection of Mice
by: S. G. Gamaley, et al.
Published: (2023-12-01)

Еxternal forms of recombinant interferon alfa-2b - ointment and gel in the treatment of acute respiratory viral infections and influenza in children
by: O. V. Shamsheva, et al.
Published: (2020-06-01)

Antibacterial, Antifungal, Antiviral Activity, and Mechanisms of Action of Plant Polyphenols
by: Slavena Davidova, et al.
Published: (2024-12-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

Deubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus.
by: Ying Ren, et al.
Published: (2016-07-01)

The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
by: V. G. Kukes, et al.
Published: (2019-12-01)

Hepatitis C Drugs: The End of the Pegylated Interferon Era and the Emergence of All-Oral, Interferon-Free Antiviral Regimens: A Concise Review
by: Alan Hoi Lun Yau, et al.
Published: (2014-01-01)

The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response
by: Kylie H. Van der Hoek, et al.
Published: (2025-04-01)

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)

Mechanisms of Antiviral Activity of Cistus Salviifolius Extract Against Human Respiratory Viruses
by: Ya. L. Esaulkova, et al.
Published: (2020-11-01)

miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14
by: Jikai Zhang, et al.
Published: (2025-08-01)

Induction of interferon-β and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells.
by: Victoria Granqvist, et al.
Published: (2021-01-01)

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)
by: Lorenza Di Marco, et al.
Published: (2025-01-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
by: L. V. Osidak, et al.
Published: (2016-09-01)

Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1)
by: A. V. Rudakova, et al.
Published: (2016-02-01)